The estimated Net Worth of Target N Vbb Biotech Ag Bio... is at least $1.75 Million dollars as of 2 April 2024. Target Bio owns over 250,000 units of Molecular Templates Inc stock worth over $1,753,353 and over the last 7 years Target sold MTEM stock worth over $0.
Target has made over 65 trades of the Molecular Templates Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Target bought 250,000 units of MTEM stock worth $587,500 on 2 April 2024.
The largest trade Target's ever made was buying 4,255,319 units of Molecular Templates Inc stock on 17 July 2023 worth over $2,000,000. On average, Target trades about 274,221 units every 35 days since 2017. As of 2 April 2024 Target still owns at least 1,279,820 units of Molecular Templates Inc stock.
You can see the complete history of Target Bio stock trades at the bottom of the page.
Over the last 7 years, insiders at Molecular Templates Inc have traded over $22,993,582 worth of Molecular Templates Inc stock and bought 14,744,530 units worth $82,519,716 . The most active insiders traders include Target N Vbb Biotech Ag Bio..., David Hirsch, and Capital Partners Iii, Llc L.... On average, Molecular Templates Inc executives and independent directors trade stock every 47 days with the average trade being worth of $532,718. The most recent stock trade was executed by Target N Vbb Biotech Ag Bio... on 2 April 2024, trading 250,000 units of MTEM stock currently worth $587,500.
molecular templates (mtem) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary engineered toxin body (etb) platform. mtem’s first immunotoxin, mt-3724, is in clinical development for non-hodgkin’s lymphoma. pipeline products for additional oncology targets are being advanced toward clinical development. for more information, please visit mtem’s website at www.mtem.com.
Molecular Templates Inc executives and other stock owners filed with the SEC include: